Cargando…
Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
BACKGROUND: Anti‐M is frequently observed as a naturally occurring antibody of little clinical significance. Naturally occurring anti‐M is often found in children although the specific triggers of production, persistence, and evanescence of anti‐M have yet to be elucidated. METHODS: In a retrospecti...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518975/ https://www.ncbi.nlm.nih.gov/pubmed/34287925 http://dx.doi.org/10.1111/trf.16594 |
_version_ | 1784584352876724224 |
---|---|
author | Tamai, Yoshiko Ohto, Hitoshi Yasuda, Hiroyasu Takeshita, Akihiro Fujii, Nobuharu Ogo, Hiroaki Yazawa, Yurika Hato, Takaaki Mitani, Kinuko Suzuki, Keijiro Yokohama, Akihiko Kato, Yoko Abe, Misao Kumagawa, Midori Ueda, Yasunori Nollet, Kenneth E. Cooling, Laura Kitazawa, Junichi |
author_facet | Tamai, Yoshiko Ohto, Hitoshi Yasuda, Hiroyasu Takeshita, Akihiro Fujii, Nobuharu Ogo, Hiroaki Yazawa, Yurika Hato, Takaaki Mitani, Kinuko Suzuki, Keijiro Yokohama, Akihiko Kato, Yoko Abe, Misao Kumagawa, Midori Ueda, Yasunori Nollet, Kenneth E. Cooling, Laura Kitazawa, Junichi |
author_sort | Tamai, Yoshiko |
collection | PubMed |
description | BACKGROUND: Anti‐M is frequently observed as a naturally occurring antibody of little clinical significance. Naturally occurring anti‐M is often found in children although the specific triggers of production, persistence, and evanescence of anti‐M have yet to be elucidated. METHODS: In a retrospective, multicenter, nationwide cohort survey conducted from 2001 to 2015, alloantibody screening was performed before and after transfusion in 18,944 recipients younger than 20 years. Recipients were categorized into six cohorts based on their age at transfusion; within and among these cohorts, allo‐anti‐M was analyzed in regard to its production, persistence, and evanescence. RESULTS: In 44 patients, anti‐M detected before and/or after transfusion was an age‐related phenomenon, with a median age of 2 years and an interquartile range of 1–3 years; anti‐M was most frequently detected in a cohort of children 1 to <5 years (0.77%, 31 of 4035). At least five patients were presumed to have concurrent infections. Among 1575 adolescents/young adults (15 to <20 years), no anti‐M was detected. Of 29 patients with anti‐M prior to transfusion, the antibody fell to undetectable levels in 17 recipients (89.5%, of whom at least 13 received only M‐negative red cells) after anywhere from 5 days to 5.8 years; anti‐M persisted in 2, and was not tested in 10. Only 15 recipients (0.08%) produced new anti‐M after transfusion. CONCLUSION: Naturally occurring anti‐M is a phenomenon of younger ages, predominantly between 1 and 3 years. After transfusion, it often falls to undetectable levels. |
format | Online Article Text |
id | pubmed-8518975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85189752021-10-21 Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion Tamai, Yoshiko Ohto, Hitoshi Yasuda, Hiroyasu Takeshita, Akihiro Fujii, Nobuharu Ogo, Hiroaki Yazawa, Yurika Hato, Takaaki Mitani, Kinuko Suzuki, Keijiro Yokohama, Akihiko Kato, Yoko Abe, Misao Kumagawa, Midori Ueda, Yasunori Nollet, Kenneth E. Cooling, Laura Kitazawa, Junichi Transfusion Immunohematology BACKGROUND: Anti‐M is frequently observed as a naturally occurring antibody of little clinical significance. Naturally occurring anti‐M is often found in children although the specific triggers of production, persistence, and evanescence of anti‐M have yet to be elucidated. METHODS: In a retrospective, multicenter, nationwide cohort survey conducted from 2001 to 2015, alloantibody screening was performed before and after transfusion in 18,944 recipients younger than 20 years. Recipients were categorized into six cohorts based on their age at transfusion; within and among these cohorts, allo‐anti‐M was analyzed in regard to its production, persistence, and evanescence. RESULTS: In 44 patients, anti‐M detected before and/or after transfusion was an age‐related phenomenon, with a median age of 2 years and an interquartile range of 1–3 years; anti‐M was most frequently detected in a cohort of children 1 to <5 years (0.77%, 31 of 4035). At least five patients were presumed to have concurrent infections. Among 1575 adolescents/young adults (15 to <20 years), no anti‐M was detected. Of 29 patients with anti‐M prior to transfusion, the antibody fell to undetectable levels in 17 recipients (89.5%, of whom at least 13 received only M‐negative red cells) after anywhere from 5 days to 5.8 years; anti‐M persisted in 2, and was not tested in 10. Only 15 recipients (0.08%) produced new anti‐M after transfusion. CONCLUSION: Naturally occurring anti‐M is a phenomenon of younger ages, predominantly between 1 and 3 years. After transfusion, it often falls to undetectable levels. John Wiley & Sons, Inc. 2021-07-21 2021-09 /pmc/articles/PMC8518975/ /pubmed/34287925 http://dx.doi.org/10.1111/trf.16594 Text en © 2021 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Immunohematology Tamai, Yoshiko Ohto, Hitoshi Yasuda, Hiroyasu Takeshita, Akihiro Fujii, Nobuharu Ogo, Hiroaki Yazawa, Yurika Hato, Takaaki Mitani, Kinuko Suzuki, Keijiro Yokohama, Akihiko Kato, Yoko Abe, Misao Kumagawa, Midori Ueda, Yasunori Nollet, Kenneth E. Cooling, Laura Kitazawa, Junichi Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion |
title |
Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion |
title_full |
Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion |
title_fullStr |
Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion |
title_full_unstemmed |
Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion |
title_short |
Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion |
title_sort | allo‐anti‐m: detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion |
topic | Immunohematology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518975/ https://www.ncbi.nlm.nih.gov/pubmed/34287925 http://dx.doi.org/10.1111/trf.16594 |
work_keys_str_mv | AT tamaiyoshiko alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT ohtohitoshi alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT yasudahiroyasu alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT takeshitaakihiro alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT fujiinobuharu alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT ogohiroaki alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT yazawayurika alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT hatotakaaki alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT mitanikinuko alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT suzukikeijiro alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT yokohamaakihiko alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT katoyoko alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT abemisao alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT kumagawamidori alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT uedayasunori alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT nolletkennethe alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT coolinglaura alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT kitazawajunichi alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion AT alloantimdetectionpeaksaround2yearsofagebutmaybeattenuatedbyredbloodcelltransfusion |